Ethicon, Inc. v. Laura Angelini ( 2017 )


Menu:
  •            Case: 16-16596   Date Filed: 05/03/2017   Page: 1 of 5
    [DO NOT PUBLISH]
    IN THE UNITED STATES COURT OF APPEALS
    FOR THE ELEVENTH CIRCUIT
    ________________________
    No. 16-16596
    Non-Argument Calendar
    ________________________
    D.C. Docket No. 3:16-cv-01124-BJD-PDB
    ETHICON, INC.,
    DEPUY ORTHOPAEDICS, INC.,
    Plaintiffs - Appellees,
    versus
    LAURA ANGELINI,
    Defendant - Appellant.
    ________________________
    Appeal from the United States District Court
    for the Middle District of Florida
    ________________________
    (May 3, 2017)
    Before WILSON, JORDAN, and ROSENBAUM, Circuit Judges.
    PER CURIAM:
    Case: 16-16596     Date Filed: 05/03/2017    Page: 2 of 5
    Laura Angelini, a former employee of Ethicon, Inc., and DePuy
    Orthopaedics, brings this interlocutory appeal of the district court’s grant of a
    motion for preliminary injunction enjoining her from beginning employment in the
    biosurgery division at Baxter Healthcare. On appeal, Angelini argues that the non-
    compete underlying the injunction is unenforceable as applied to her because she
    lacks intimate knowledge of the alleged confidential information that the non-
    compete seeks to protect. Angelini also argues that the district court lacked
    authority to grant the motion not only because there was no “actual and imminent”
    injury but also because the district court failed to hold an evidentiary hearing.
    After a careful review of the parties’ briefs and the record, we agree that an
    evidentiary hearing was necessary. We vacate and remand for proceedings
    consistent with this opinion.
    Ethicon and DePuy are companies within Johnson and Johnson’s (J&J)
    Medical Device sector. J&J, a multinational conglomerate comprised of more
    than 260 companies, is the world’s largest medical device, consumer products and
    pharmaceutical company. Its Medical Device sector alone is comprised of several
    companies, including both Ethicon and DePuy. Ethicon develops, manufactures,
    and markets biosurgery products that are dedicated to minimizing operation
    complications for surgical conditions that are difficult to manage through the use
    of standard surgical techniques. DePuy develops, manufactures, and markets
    2
    Case: 16-16596    Date Filed: 05/03/2017    Page: 3 of 5
    implants and instrumentation for use in orthopedic surgeries that repair and heal
    the musculoskeletal system.
    Angelini has worked in various marketing positions, in various J&J
    companies, for over 20 years. In her most recent position at J&J, Angelini re-
    entered the Medical Device sector, after a three-year hiatus, as the Global
    Platform Leader for Joints at DePuy. At DePuy she was responsible for
    managing upstream marketing for orthopedic products such as hips, knees, and
    power drills used in orthopedic surgery. Upon taking this position, Angelini
    executed an 18-month restrictive covenant that prevents her from performing
    work for any competitor, of any of J&J’s companies, if she could disclose or use
    confidential information to advantage the competitor and disadvantage J&J. The
    covenant also contains a New Jersey choice-of-law provision.
    Angelini’s position as the Global Platform Leader for DePuy gave her access
    to confidential emails and required her to attend and present at a three-day
    workshop comprised of presentations by J&J’s various Medical Device
    businesses. Ethicon gave a 20 minute substantive presentation at the workshop,
    which consisted of pre-read material and other accompanying oral remarks by the
    presenter regarding confidential information about a number of Ethicon’s
    products. The confidential emails that Angelini received and Ethicon’s 20-minute
    substantive presentation at the workshop are at issue here.
    3
    Case: 16-16596      Date Filed: 05/03/2017    Page: 4 of 5
    We review a district court’s grant of a preliminary injunction for an abuse of
    discretion, and we review the district court’s findings of fact for clear error.
    Johnson & Johnson Vision Care, Inc. v. 1-800 Contacts, Inc., 
    299 F.3d 1242
    ,
    1246 (11th Cir. 2002). Our review of the district court’s application of the law,
    however, is de novo. 
    Id.
    “We may reverse the district court’s order only if there was a clear abuse of
    discretion.” Siegel v. LePore, 
    234 F.3d 1163
    , 1175 (11th Cir. 2000) (per curiam)
    (en banc) (emphasis in original). A district court abuses its discretion in granting
    a preliminary injunction without holding an evidentiary hearing if “the injunction
    turns on the resolution of bitterly disputed facts” and there is a need “to decide
    credibility issues.” All Care Nursing Serv. Inc. v. Bethesda Mem’l Hosp. Inc.,
    
    887 F.2d 1535
    , 1538 (11th Cir. 1989).
    While Angelini’s attendance at the workshop is undisputed, the significance
    of her attendance is disputed. The parties dispute whether Angelini became privy
    to Ethicon’s confidential information through her presence at the workshop and
    her receipt of some confidential emails. Specifically, the parties dispute the level
    and scope of Angelini’s participation at the workshop and Angelini’s familiarity
    and knowledge of the information in the pre-read materials and the emails.
    Angelini argues that she is not privy to Ethicon’s confidential information
    because she did not read the pre-read materials or the emails and because she has
    4
    Case: 16-16596     Date Filed: 05/03/2017    Page: 5 of 5
    no recollection of the information provided to her. Ethicon and DePuy argue that
    Angelini is privy not only because was she continuously exposed to confidential
    information in her position at DePuy, but also because she participated in the
    workshop and asked questions during Ethicon’s presentation.
    In granting the injunction, the district court abused its discretion by making
    credibility determinations without an evidentiary hearing. See 
    id.
     In determining
    that Angelini is privy to the confidential information, the court credited the
    statements of individuals claiming that Angelini participated during Ethicon’s
    presentation, in the face of Angelini’s own statement that she paid no attention to
    either the pre-read materials or the emails. Indeed, the district court’s
    interpretation of the statements provided is plausible. Angelini could have been
    paying close attention to Ethicon’s presentation and she could have been actively
    participating in the sharing of that information, meaning that she is in fact privy to
    the confidential information at issue. But the opposite conclusion is just as
    plausible. And “[i]n the face of two plausible interpretations of evidence
    submitted to demonstrate a contested issue, the district court is not at liberty to
    accept one construction of the evidence and reject the other without the benefit of
    an evidentiary hearing.” CBS Broad. Inc. v. EchoStar Commc’n Corp., 
    265 F.3d 1193
    , 1207–08 (11th Cir. 2001).
    VACATED and REMANDED.
    5
    

Document Info

Docket Number: 16-16596 Non-Argument Calendar

Judges: Wilson, Jordan, Rosenbaum

Filed Date: 5/3/2017

Precedential Status: Non-Precedential

Modified Date: 10/19/2024